Clinical Testing Sample Clauses
The Clinical Testing clause defines the requirements and procedures for conducting clinical trials or studies involving a product, drug, or medical device. It typically outlines the standards for trial design, ethical considerations, regulatory compliance, and data collection, and may specify responsibilities for obtaining approvals or reporting results. By establishing clear guidelines for how clinical testing must be performed, this clause ensures that all parties adhere to legal and ethical standards, thereby protecting patient safety and supporting the validity of study outcomes.
Clinical Testing. All pre-clinical, clinical and post-clinical testing and stability testing and other actions, including but not limited to completion of the Development Program, required to obtain all requisite government approvals in the United States for the manufacture and sale of each Licensed Product shall be conducted by SANO, at its expense unless otherwise set forth herein.
Clinical Testing. The parties will use commercially reasonable efforts to perform their respective obligations set forth in the Development Program for the Clinical Testing of the Product and obtaining of Regulatory Approval for the Finished Product.
Clinical Testing. If SMI desires to conduct any clinical testing of the Monitor, where the data from such testing is expected to be presented at a public forum or be published, SMI shall advise Aspect and no such clinical testing shall occur unless Aspect shall first have approved the protocols for such clinical testing. Aspect shall not unreasonably delay or withhold its approval of such clinical testing.
Clinical Testing. All pre-clinical, clinical and post-clinical testing and stability testing including but not limited to the Clinical Product Development Program required for government health care approvals in the Territory of a Licensed Product developed by Noven shall be conducted by Noven and Rore▇, ▇▇ Rore▇'▇ ▇▇▇e expense, it being understood that Noven shall perform the clinical testing for the United States and Canada at Rore▇'▇ ▇▇▇e expense. However, before clinical testing of a product is commenced, Noven shall complete all of Rore▇'▇ ▇▇▇-clinical testing requirements set forth in Exhibit A for the Licensed Product except for the U.S. and Canada.
Clinical Testing. Upon completion of Licensee’s initial development work to incorporate the Licensed Ingredients into Products, Licensee will clinically test the initial Product in accordance with a clinical test schedule to be determined by Licensee to determine whether the Product performs in accordance with the clinical results specifications set forth in Exhibit C. Such clinical testing will be conducted in accordance with the protocols and procedures and at the locations set forth in Exhibit C, or as otherwise agreed to among Licensee, its subcontractor RF Technology Consultants Inc. (“RF Technology”), and BioKool in writing.
Clinical Testing. No royalties shall accrue for the sale of ---------------- Licensed Products in conjunction with clinical tests or trials conducted in accordance with the guidelines of the U.S. Food and Drug Administration and any other appropriate governmental agency.